{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:07:56Z","timestamp":1790140076589,"version":"4.0.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017559","name":"Recordati Rare Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Cushing syndrome (CS) is associated with significant morbidity and mortality, but data from the Middle East, including Saudi Arabia, are limited. This study aimed to characterize the demographics, clinical features, comorbidities, diagnostic findings, treatments, and outcomes in a Saudi Arabian multicenter tertiary-referral cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective multicenter study, 146 patients with confirmed CS were included. Demographics, clinical features, laboratory and imaging results, treatments, and outcomes were collected and analyzed according to etiological subtype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 146 patients (114 women, 32 men; mean age at last recorded follow-up or data abstraction, 42.2 \u00b1\u00a014.7 years), pituitary CS was the most common etiology (61.0%). The mean diagnostic delay was 7.5 years (median 5 years). Hypertension (62.3%) and dysglycemia (67.1%) were prevalent. Among the 88 patients who underwent bone mineral density assessment, 71.6% had abnormal bone health; this selected-subgroup estimate should not be generalized to the entire cohort. Hypokalemia was frequent in ectopic CS (84.6%). Treatment was etiology-specific: 85.4% of the patients with pituitary CS underwent transsphenoidal surgery (TSS), and 87.9% of patients with adrenal CS who underwent adrenalectomy had a unilateral procedure. Crude mortality was 5.1% (7\/138 patients with known vital status), remission was documented in 66.9% (93\/139 with recorded outcomes), and recurrence after a documented remission occurred in 12 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this Saudi Arabian multicenter tertiary-referral cohort, CS predominantly affects women and is most frequently attributable to pituitary CS. Diagnostic delay remains prolonged despite advances in diagnosis and management. Descriptive treatment outcomes were broadly consistent with international experience; crude mortality was 5.1% among patients with known vital status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1948006","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:50:01Z","timestamp":1790139001000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features, comorbidities, and therapeutic outcomes of Cushing syndrome: a retrospective multicenter study from Saudi Arabia"],"prefix":"10.3389","volume":"17","author":[{"given":"Mussa H.","family":"Almalki","sequence":"first","affiliation":[{"name":"Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Second Health Cluster","place":["Riyadh, Saudi Arabia"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alamri","sequence":"additional","affiliation":[{"name":"Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Second Health Cluster","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara H.","family":"Musa","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan W.","family":"Kawsara","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishah","family":"Ekhzaimy","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Unit, Department of Medicine, College of Medicine and King Saud University Medical City, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeber","family":"Mahzari","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud bin Abdulaziz University for Health Sciences","place":["Riyadh, Saudi Arabia"]},{"name":"King Abdullah International Medical Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"Department of Medicine, Ministry of National Guard Health Affairs","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Z.","family":"Almutairi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Security Forces Hospital","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadei","family":"Elhakimi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, Almoosa Specialist Hospital","place":["Al Mubarraz, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Hummadi","sequence":"additional","affiliation":[{"name":"Adult Endocrinology and Diabetes Center, Jazan Health Cluster","place":["Ministry of Health, Jazan, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Alqambar","sequence":"additional","affiliation":[{"name":"Adult Endocrinology Unit, King Fahad Specialist Hospital","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]},{"name":"Molecular Endocrine Section, Research and Innovation, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/clep.s44336","article-title":"Cushing's syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing Syndrome: A Review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.1.117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302007000800025","article-title":"Cushing's syndrome: aftermath of the cure","volume":"51","author":"Pivonello","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/erc-24-0028","article-title":"Insights on epidemiology, morbidity, and mortality of Cushing's disease in Northern Ireland","volume":"31","author":"Loughrey","year":"2024","journal-title":"Endocr Relat Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00588-w","article-title":"Cushing syndrome","volume":"11","author":"Nieman","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B11","doi-asserted-by":"publisher","first-page":"dgz136","DOI":"10.4324\/9781003141754-3","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/eje-13-0569","article-title":"Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-00951-1","article-title":"The incidence of Cushing's disease: a nationwide Swedish study","volume":"22","author":"Ragnarsson","year":"2019","journal-title":"Pituitary"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13186","article-title":"Long-term follow-up and predictors of recurrence of Cushing's disease","volume":"34","author":"Guignat","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaf042","article-title":"Update and practical recommendations for the use of medical treatment of Cushing syndrome","volume":"47","author":"Araujo-Castro","year":"2026","journal-title":"Endocr Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/eje-16-0967","article-title":"Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN","volume":"176","author":"Valassi","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/eje-11-1095","article-title":"The burden of Cushing's disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B22","volume-title":"Idf Diabetes Atlas","year":"2025"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40618-024-02450-y","article-title":"Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how","volume":"48","author":"Giordano","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-024-01427-7","article-title":"Cushing's disease and bone","volume":"27","author":"Zdrojowy-Welna","year":"2024","journal-title":"Pituitary"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000029054","article-title":"Clinical correlates of major depression in Cushing's disease","volume":"31","author":"Sonino","year":"1998","journal-title":"Psychopathology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2013.05.010","article-title":"Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration","volume":"42","author":"Starkman","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/20420188261434078","article-title":"Clinical characteristics, diagnosis, and treatment of Cushing's syndrome: analysis of a multicenter registry in Antioquia, Colombia","volume":"17","author":"Rivera-Mart\u00ednez","year":"2026","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3171\/2017.12.jns172318","article-title":"Complications associated with transsphenoidal pituitary surgery: experience of 1153 consecutive cases","volume":"130","author":"Agam","year":"2018","journal-title":"J Neurosurg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1665985","article-title":"Management of patients with Cushing's disease in the Gulf Region: a Delphi consensus recommendation","volume":"16","author":"Almalki","year":"2025","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1948006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:50:09Z","timestamp":1790139009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1948006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":31,"alternative-id":["10.3389\/fendo.2026.1948006"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1948006","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1948006"}}